Synjardy 5/500 mg; Synjardy 5/850 mg; Synjardy 5/1000 mg; Synjardy 12,5/500 mg; Synjardy 12,5/850 mg; Synjardy 12,5/1000 mg
Film-coated tablets
registration number
49/21.2/0915; 49/21.2/0916; 49/21.2/0917; 49/21.2/0918; 49/21.2/0919; 49/21.2/0920
What Synjardy 5/500 mg; Synjardy 5/850 mg; Synjardy 5/1000 mg; Synjardy 12,5/500 mg; Synjardy 12,5/850 mg; Synjardy 12,5/1000 mg contains
SYNJARDY 5/500 mg contains 5 mg empagliflozin and 500 mg metformin hydrochloride
SYNJARDY 5/850 mg contains 5 mg empagliflozin and 850 mg metformin hydrochloride
SYNJARDY 5/1000 mg contains 5 mg empagliflozin and 1 000 mg metformin hydrochloride
SYNJARDY 12,5/500 mg contains 12,5 mg empagliflozin and 500 mg metformin hydrochloride
SYNJARDY 12,5/850 mg contains 12,5 mg empagliflozin and 850 mg metformin hydrochloride
SYNJARDY 12,5/1000 mg contains 12,5 mg empagliflozin and 1 000 mg metformin hydrochloride.
other ingredients
Each film-coated tablet of SYNJARDY contains the following inactive ingredients: colloidal anhydrous silica, copovidone, hypromellose, iron oxide black (SYNJARDY 12,5/500 mg, SYNJARDY 12,5/850 mg, SYNJARDY 12,5/1000 mg), iron oxide red (SYNJARDY 12,5/500 mg, SYNJARDY 12,5/850 mg, SYNJARDY 12,5/1000 mg), iron oxide yellow (SYNJARDY 5/500 mg, SYNJARDY 5/850 mg, SYNJARDY 5/1000 mg), macrogol 400, magnesium stearate, maize starch, talc, titanium dioxide.
Therapeutic classification
A10BD20.